Concepedia

Jana L. Laidlaw

JL

7

Publications

606

Citations

7

H-Index

1975

Active since

Affiliations

Anderson Hospital(Current)

The University of Texas Health Science Center at Houston

The University of Texas System

Jana L. Laidlaw is an author at Anderson Hospital specializing in medicine, pharmacology, and biomedical engineering.

Top concepts

Publications per year

1975–1999

7

Publications

7

PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes

Susana Velasco-Miguel, Leonard Buckbinder, Patrice Jean et al. · Oncogene · 1999 · 253 citations

, , +9

The effect of proteoglycans on the formation of fibrils from collagen solutions

Theodore R. Oegema, Jana L. Laidlaw, Vincent Hascall et al. · Archives of Biochemistry and Biophysics · 1975 · 137 citations · Full text

, , +6

Degradation and Inactivation of Antitumor Drugs

John A. Benvenuto, Thomas H. Connor, David Monteith et al. · Journal of Pharmaceutical Sciences · 1993 · 94 citations

, , +6

Permeability of latex and polyvinyl chloride gloves to 20 antineoplastic drugs

Jana L. Laidlaw, Thomas H. Connor, Jeffrey C. Theiss et al. · American Journal of Health-System Pharmacy · 1984 · 52 citations

, , +17

Permeability of latex and polyvinyl chloride gloves to carmustine

Thomas H. Connor, Jana L. Laidlaw, Jeffrey C. Theiss et al. · American Journal of Health-System Pharmacy · 1984 · 33 citations

, , +16

Rows per page

1–5 of 7